Abstract:Hydrogen sulfide (H2S), a gaseous signaling molecule, is associated with the development of various malignancies via modulating various cellular signaling cascades. Published research has established the fact that inhibition of endogenous H2S production or exposure of H2S donors is an effective approach against cancer progression. However, the effect of pharmacological inhibition of endogenous H2S-producing enzymes (cystathionine-γ-lyase (CSE), cystathionine-β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3-MPST)) on the growth of breast cancer (BC) remains unknown. In the present study, DL-propargylglycine (PAG, inhibitor of CSE), aminooxyacetic acid (AOAA, inhibitor of CBS), and L-aspartic acid (L-Asp, inhibitor of 3-MPST) were used to determine the role of endogenous H2S in the growth of BC by in vitro and in vivo experiments. An in silico study was also performed to confirm the results. Corresponding to each enzyme in separate groups, we treated BC cells (MCF-7 and MDA-MB-231) with 10 mM of PAG, AOAA, and L-Asp for 24 h. Findings reveal that the combined dose (PAG + AOAA + L-Asp) group showed exclusive inhibitory effects on BC cells' viability, proliferation, migration, and invasion compared to the control group. Further, treated cells exhibited increased apoptosis and a reduced level of phospho (p)-extracellular signal-regulated protein kinases such as p-AKT, p-PI3K, and p-mTOR. Moreover, the combined group exhibited potent inhibitory effects on the growth of BC xenograft tumors in nude mice, without obvious toxicity. The molecular docking results were consistent with the wet lab experiments and enhanced the reliability of the drugs. In conclusion, our results demonstrate that the inhibition of endogenous H2S production can significantly inhibit the growth of human breast cancer cells via the AKT/PI3K/mTOR pathway and suggest that endogenous H2S may act as a promising therapeutic target in human BC cells. Our study also empowers the rationale to design novel H2S-based anti-tumor drugs to cure BC.

Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways

Nanotherapeutics for Hydrogen Sulfide-Involved Treatment: an Emerging Approach for Cancer Therapy

Hydrogen Sulfide Contributes to Hypoxia-Induced Radioresistance on Hepatoma Cells

Exogenous Hydrogen Sulfide Regulates the Growth of Human Thyroid Carcinoma Cells

Hydrogen Sulfide Demonstrates Promising Antitumor Efficacy in Gastric Carcinoma by Targeting MGAT5.

Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer

Hydrogen Sulfide Induces Human Colon Cancer Cell Proliferation: Role of Akt, ERK and P21

Effects of Hydrogen Sulfide, A New Gaseous Signal Molecule, on Proliferation and Metabolism of HepG2

An Anticancer Role Of Hydrogen Sulfide In Human Gastric Cancer Cells

The Role of Hydrogen Sulfide in the Development and Progression of Lung Cancer

Role of hydrogen sulfide donors in cancer development and progression

Blocking Endogenous H2S Signaling Attenuated Radiation-Induced Long-Term Metastasis of Residual HepG2 Cells Through Inhibition of EMT.

Hydrogen Sulfide Attenuated Tumor Necrosis Factor-α-Induced Inflammatory Signaling and Dysfunction in Vascular Endothelial Cells

Hydrogen Sulfide Biology and Its Role in Cancer

H2S Suppresses Indoleamine 2, 3-Dioxygenase 1 and Exhibits Immunotherapeutic Efficacy in Murine Hepatocellular Carcinoma

Endogenous hydrogen sulfide inhibition suppresses tumor growth by promoting apoptosis and pyroptosis in esophageal cancer cells

Emerging roles of hydrogen sulfide in colorectal cancer

Hydrogen Sulfide-Evoked Intracellular Ca2+ Signals in Primary Cultures of Metastatic Colorectal Cancer Cells

A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

Hydrogen Sulfide and Its Donors: Novel Antitumor and Antimetastatic Therapies for Triple-Negative Breast Cancer

Pharmacological Inhibition of Endogenous Hydrogen Sulfide Attenuates Breast Cancer Progression